| Curtis Austin, PHARMD | |
|
781 Leonard Ave, Albemarle, NC 28001-5257 | |
| (704) 983-6830 | |
| Not Available |
| Full Name | Curtis Austin |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 781 Leonard Ave, Albemarle, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255886248 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 26283 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Curtis Austin, PHARMD 781 Leonard Ave, Albemarle, NC 28001-5257 Ph: (704) 983-6830 | Curtis Austin, PHARMD 781 Leonard Ave, Albemarle, NC 28001-5257 Ph: (704) 983-6830 |
News Archive
Global regenerative medicine company Mesoblast Limited (ASX:MSB) has announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) for non-surgical restoration of degenerated intervertebral discs and treatment of low back pain has enrolled 50% of the total study patients. This rapid rate of enrolment attests to the major unmet medical need and to the relative simplicity of Mesoblast's non-surgical procedure. Mesoblast expects to complete full enrolment by early third quarter.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
Anti-NMDAR encephalitis is an autoimmune brain illness that is often mistaken by a psychiatric disorder since it causes psychoses and other behaviour alterations. Despite having these similarities, the illness does not respond to common antipsychotic treatments.
Early age at menarche, or first menstrual cycle, could play a role in the disproportionate incidence of estrogen receptor (ER)-negative breast cancers diagnosed among African-American women, according to a study published in the Journal of the National Cancer Institute.
› Verified 4 days ago
Harry Thomas Murrell Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50027 Haven Cove Rd, Albemarle, NC 28001 Phone: 704-983-2549 | |
Jenny Mabry, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 835 Highway 24-27, Albemarle, NC 28001 Phone: 704-983-2192 Fax: 704-983-8763 | |
Mr. Stanley Robert Leggett, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 Salisbury Ave, Albemarle, NC 28001 Phone: 704-982-1145 | |
Mrs. Jennifer Willeford, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 781 Leonard Ave, Albemarle, NC 28001 Phone: 704-982-8948 | |
Dr. Elaine R. Thomas, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Yadkin St, Stanly Regional Medical Center, Albemarle, NC 28001 Phone: 704-984-4686 Fax: 704-983-7846 | |
Margaret Zyra, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 Salisbury Ave, Albemarle, NC 28001 Phone: 704-982-1145 |